company background image
SGFY logo

Signify Health NYSE:SGFY Stock Report

Last Price

US$30.49

Market Cap

US$7.2b

7D

5.5%

1Y

68.0%

Updated

30 Mar, 2023

Data

Company Financials +

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

SGFY Stock Overview

Signify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. More details

SGFY fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance5/6
Financial Health4/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for SGFY from our risk checks.

My Notes

Capture your thoughts, links and company narrative

Signify Health, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Signify Health
Historical stock prices
Current Share PriceUS$30.49
52 Week HighUS$30.50
52 Week LowUS$10.70
Beta0.36
1 Month Change5.90%
3 Month Change6.39%
1 Year Change67.99%
3 Year Changen/a
5 Year Changen/a
Change since IPO-3.39%

Recent News & Updates

CVS Health to offer bonds to finance purchase of Signify Health

Feb 13

Signify Health and Prospect Medical come together to deliver coordinated, high-quality care

Jan 11

Checking Signify Health Before The CVS Transaction

Dec 21

Recent updates

CVS Health to offer bonds to finance purchase of Signify Health

Feb 13

Signify Health and Prospect Medical come together to deliver coordinated, high-quality care

Jan 11

Checking Signify Health Before The CVS Transaction

Dec 21

Signify expands diagnostic offering with spirometry test for lung disease

Oct 18

Signify Health jumps on report CVS in talks to acquire for about $8 billion

Sep 02

Signify Health: Cathie Wood Now Selling

Aug 15

CVS Health seeking purchase of Signify Health - WSJ

Aug 07

Signify Health: ECS Wind Down Sheds Light On Compelling Valuation

Jul 21

Signify Health Aims Higher With New CMS Terms

Mar 16

Revisiting Signify Health

Jan 09

Signify Health names Susan Yun as chief people officer

Jun 02

Shareholder Returns

SGFYUS HealthcareUS Market
7D5.5%-5.0%-3.5%
1Y68.0%-11.4%22.1%

Return vs Industry: SGFY exceeded the US Healthcare industry which returned -14.7% over the past year.

Return vs Market: SGFY exceeded the US Market which returned -16% over the past year.

Price Volatility

Is SGFY's price volatile compared to industry and market?
SGFY volatility
SGFY Average Weekly Movement2.0%
Healthcare Industry Average Movement7.6%
Market Average Movement6.3%
10% most volatile stocks in US Market17.0%
10% least volatile stocks in US Market3.1%

Stable Share Price: SGFY has not had significant price volatility in the past 3 months.

Volatility Over Time: SGFY's weekly volatility has decreased from 8% to 2% over the past year.

About the Company

FoundedEmployeesCEOWebsite
20172,150Bradford Armbresterwww.signifyhealth.com

Signify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates through Home & Community Services and Episodes of Care Services segments. The Home & Community Services segment offers health evaluations performed within the patient’s home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health.

Signify Health, Inc. Fundamentals Summary

How do Signify Health's earnings and revenue compare to its market cap?
SGFY fundamental statistics
Market capUS$7.21b
Earnings (TTM)US$76.50m
Revenue (TTM)US$805.50m

71.4x

P/E Ratio

6.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SGFY income statement (TTM)
RevenueUS$805.50m
Cost of RevenueUS$440.40m
Gross ProfitUS$365.10m
Other ExpensesUS$288.60m
EarningsUS$76.50m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.43
Gross Margin45.33%
Net Profit Margin9.50%
Debt/Equity Ratio41.0%

How did SGFY perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/03/30 23:38
End of Day Share Price 2023/03/28 00:00
Earnings2022/12/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Signify Health, Inc. is covered by 14 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vikram KesavabhotlaBaird
Steven ValiquetteBarclays
Sarah JamesBarclays